TIVC (Tivic Health Systems) Rasio tanggungan utang jangka dawa marang modal

Tivic Health Systems (TIVC) business scalability relies on the release of electronic gadgets for treating nasal congestion, as confirmed by the current share price action shown on the chart, where the indicator stands at 0.00. Stable revenue is driven by long-term service utilization and hardware upgrades by patients with chronic sinusitis. However, the lack of insurance reimbursements in the US and direct marketing costs for ClearUP constrain profit growth, despite the uniqueness of the bioelectronic device.

This metric is calculated as the ratio of liabilities with a maturity of over one year to equity. It measures the extent of the company's reliance on external borrowing to finance assets. For Tivic Health Systems (TIVC), this is critical, as expansion into pharmacy chains and DTC marketing requires stable capital. Analyzing financial leverage based on long-term debt allows for an assessment of the business's resilience to credit risks.